Stock ALTIMMUNE INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Press Releases Altimmune Inc Nyse

Equities

US71714G1022

End-of-day quote Nyse
Other stock markets
- USD - Intraday chart for Altimmune Inc
May. 09 Transcript : Altimmune, Inc., Q1 2024 Earnings Call, May 09, 2024
May. 09 Earnings Flash (ALT) ALTIMMUNE Reports Q1 Revenue $5,000 MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Altimmune, Inc. Investor Notice: Robbins LLP Reminds Stockholders of the Altimmune, Inc. (ALT) Class Action
BU
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Altimmune, Inc. (ALT) Investors
BU
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Altimmune, Inc.(ALT) Shareholders
PR
INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Altimmune Inc. to Contact Law Firm
PR
Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Altimmune, Inc. (ALT) Investors
BU
Altimmune Announces First Quarter 2024 Financial Results and Provides a Business Update
AQ
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Altimmune, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ALT
PR
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Altimmune, Inc. (ALT) on Behalf of Investors
BU
ALT Bronstein, Gewirtz & Grossman LLC Announces that Altimmune, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
PR
Law Offices of Howard G. Smith Announces Investigation of Altimmune, Inc. (ALT) on Behalf of Investors
BU
The Law Offices of Frank R. Cruz Announces Investigation of Altimmune, Inc. (ALT) on Behalf of Investors
BU
ROSEN, A LEADING LAW FIRM, Encourages Altimmune, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – ALT
BU
Altimmune to Participate at Two Upcoming Investor Conferences
AQ
Pomerantz Law Firm Announces the Filing of a Class Action Against Altimmune, Inc. and Certain Officers - ALT
PR
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune
PR
Altimmune to Report First Quarter 2024 Financial Results and Provide Business Update on May 9, 2024
AQ
Altimmune to Participate at Two Upcoming Conferences
AQ
Altimmune Statement on the Passing of Dr. Stephen Harrison
AQ
Altimmune Announces Positive Lean Mass Preservation Data for Pemvidutide and Reports Fourth Quarter and Full Year 2023 Financial Results
AQ
Altimmune to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on March 27, 2024
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ALT Stock
  4. Stock
  5. News Altimmune Inc
  6. Press Releases
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW